Skip to content
Home
Close Home
Open Home
Journal information
Editorial board
Operations manual
Editorial policies
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Close Read
Open Read
Archive
TOC Alert
Current issue
Information
Close Information
Open Information
Editorial & Peer Review
Ethical policies
Funding
Complaints and appeals
Open access and licensing
Authors
Sponsorship
Contact
Publish
Close Publish
Open Publish
Instructions to authors
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
ES
EN
0,00
€
0
Cart
TOC Alert
2008
Ritonavir-Boosted Protease Inhibitor Monotherapy for the Treatment of HIV-1 Infection
HIV-1 Drug Resistance Mutations: an Updated Framework for the Second Decade of HAART
Resilience to Resistance of HIV-1 Protease Inhibitors: Profile of Darunavir
HTLV-1 Yin and Yang: Rex and p30 Master Regulators of Viral mRNA Trafficking
Pathogenesis of Liver Damage in HCV-HIV Patients
Effect of HIV Infection on the Course of Syphilis
HIV Coreceptor Phenotyping in the Clinical Setting
Boosted Protease Inhibitor-Based or Nonnucleoside Reverse Transcriptase-Based HAART: Is There a Best Choice for Antiretroviral-Naive HIV-1 Infected Patients?
Multicentric Castleman’s Disease in HIV Infection: a Systematic Review of the Literature
Minority Report: Hidden Memory Genomes in HIV-1 Quasispecies and Possible Clinical Implications